Related Experiment Video
Updated: Aug 15, 2025

07:48
A Silver Nanoparticle Method for Ameliorating Biliary Atresia Syndrome in Mice
Published on: October 13, 2018
7.7K
Genotoxicity and Toxicity Assessment of a Formulation Containing Silver Nanoparticles and Kaolin: An In Vivo
Adriana Rodriguez-Garraus1, María Alonso-Jauregui1, Ana-Gloria Gil1
1Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.
Nanomaterials (Basel, Switzerland)
|January 8, 2023
Summary
This study found that a novel silver-kaolin material, a potential antibiotic alternative in animal feed, showed no genotoxicity in rats. Safety assessments confirmed its safety for use in animal nutrition.
Area of Science:
- Materials Science
- Toxicology
- Nanotechnology
Background:
- Antibiotic use in animal feed is under scrutiny.
- Silver nanoparticles (AgNPs) on a kaolin base offer a potential alternative.
- In vivo genotoxicity assessment is crucial for safety.
Purpose of the Study:
- To evaluate the in vivo genotoxic potential of a silver-kaolin formulation.
- To establish a No Observed Adverse Effect Level (NOAEL) for the material.
- To assess the safety of AgNPs-kaolin as an animal feed supplement.
Main Methods:
- A 28-day repeated dose oral toxicity study in rats (TG 407).
- Inclusion of the Micronucleus test (TG 474) and Comet assay (TG 489).
- Quantification of silver in target organs using ICP-MS.
Main Results:
- A NOAEL of 2000 mg/kg b.w./day was determined for the silver-kaolin formulation.
- No induction of micronuclei or DNA strand breaks was observed in any tested tissues.
- No oxidized bases were detected, and silver levels confirmed distribution without toxicity.
Conclusions:
- The silver-kaolin formulation is not genotoxic in rats under the tested conditions.
- The material demonstrates a favorable safety profile for potential use in animal feed.
- Further research can explore its efficacy as an antibiotic alternative.
Related Concept Videos
Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
Toxic Reactions: Overview
1.1K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.1K

